Here are eight research and development projects regarding orthopedic and spine devices.
DePuy Orthopaedics recently announced its plan to spend $7 million on research and development equipment for its company by 2014. At the same time, it announced plans to spend $20 million on manufacturing equipment.
Surgeons and surgery centers around the country have been participating in research trials for the personalized knee replacement technology produced by ConforMIS. Battle Creek, Mich.-based Brookside Surgery Center is participating in a study for the company's iUni G2 knee resurfacing device. The company has also reported successful use of its total knee replacement product, iTotal.
Surgeons at the Hospital for Special Surgery are working on studying the outcomes of joint replacements for patients over the age of 50 after they return to regular activity. The study is looking at long-lasting joint implants, including a "30-year knee" implant approved by the FDA which withstood the simulation of 30 years in use.
Following the release of new studies questioning the initially reported relationship between Medtronic's bone morphogenic protein Infuse and RE, the company has funded Yale researchers to conduct a review of the initial trials on the product. Infuse, which is cleared by the FDA, is used to promote fusion during spine surgery.
NovaBone opened a new research and development facility in Gainesville, Fla. The 3,500-square-foot building will be used to develop the company's bone graft substitutes for orthopedic and dental applications.
Stryker recently announced a partnership with OrthoSensor to study the company's technology with the Triathlon Knee. The OrthoSensor Knee Trial is an intelligent trail design to provide quantitative, intraoperative feedback, which allows surgeons to balance the joint during total knee arthroplasty.
Spine device company Synthes has partnered with Eli Lilly and Company to develop site-specific osteoinductive products based on Synthes' biomaterials and Lilly's biologics or pharmaceuticals business. The companies will also fund and conduct evaluation of additional orthopedic uses for Lilly's osteoporosis drug Forteo.
Researchers at the University of Pittsburgh have been using a wireless chip they patented to track and monitor surgical implants. The chip is attached to orthopedic devices and tells the surgeon about the pressure of the implant, chemical balance, temperature of the surrounding tissue and nearby harmful organisms.
Related Articles on Orthopedics:
20 Orthopedic and Spine Device Company Executive Moves
Smith & Nephew Stocks Soar Amid Takeover Rumors
Generic Orthopedic Implants’ Time Has Come
Surgeons and surgery centers around the country have been participating in research trials for the personalized knee replacement technology produced by ConforMIS. Battle Creek, Mich.-based Brookside Surgery Center is participating in a study for the company's iUni G2 knee resurfacing device. The company has also reported successful use of its total knee replacement product, iTotal.
Surgeons at the Hospital for Special Surgery are working on studying the outcomes of joint replacements for patients over the age of 50 after they return to regular activity. The study is looking at long-lasting joint implants, including a "30-year knee" implant approved by the FDA which withstood the simulation of 30 years in use.
Following the release of new studies questioning the initially reported relationship between Medtronic's bone morphogenic protein Infuse and RE, the company has funded Yale researchers to conduct a review of the initial trials on the product. Infuse, which is cleared by the FDA, is used to promote fusion during spine surgery.
NovaBone opened a new research and development facility in Gainesville, Fla. The 3,500-square-foot building will be used to develop the company's bone graft substitutes for orthopedic and dental applications.
Stryker recently announced a partnership with OrthoSensor to study the company's technology with the Triathlon Knee. The OrthoSensor Knee Trial is an intelligent trail design to provide quantitative, intraoperative feedback, which allows surgeons to balance the joint during total knee arthroplasty.
Spine device company Synthes has partnered with Eli Lilly and Company to develop site-specific osteoinductive products based on Synthes' biomaterials and Lilly's biologics or pharmaceuticals business. The companies will also fund and conduct evaluation of additional orthopedic uses for Lilly's osteoporosis drug Forteo.
Researchers at the University of Pittsburgh have been using a wireless chip they patented to track and monitor surgical implants. The chip is attached to orthopedic devices and tells the surgeon about the pressure of the implant, chemical balance, temperature of the surrounding tissue and nearby harmful organisms.
Related Articles on Orthopedics:
20 Orthopedic and Spine Device Company Executive Moves
Smith & Nephew Stocks Soar Amid Takeover Rumors
Generic Orthopedic Implants’ Time Has Come